【レポートの概要（一部）】
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Biosimilars: Overview
• Comparative analysis of biosimilars and generics
• Biosimilars market opportunities
• Challenges for new entrants
PART 06: Erythropoietin: An overview
• Clinical uses of EPO
• Abusive uses of EPO
• Risks of EPO use
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Pipeline portfolio
• Phase III pipeline portfolio
• Phase II pipeline portfolio
• Phase I pipeline portfolio
• Pre-clinical pipeline portfolio
PART 09: Marketed products portfolio
PART 10: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 11: Market segmentation by application
• End-stage renal disease
• Cancer
• HIV
• Wounds and neural disease
PART 12: Market segmentation by product
• First-generation erythropoietin formulation
• Second-generation erythropoietin formulation
• Biosimilars
PART 13: Geographical segmentation
• Erythropoietin drugs market in EMEA
• Erythropoietin drugs market in Europe
• Erythropoietin drugs market in Americas
• Erythropoietin drugs market in US
• Erythropoietin drugs market in APAC
• Erythropoietin drugs market in China
• Erythropoietin drugs market in Japan
• Market overview
PART 14: Market drivers
• Rise in number of patent expiries
• Need for cost-effective treatment
• Increase in CKD and dialysis patient pool
PART 15: Impact of drivers
PART 16: Market challenges
• Physicians’ reluctance to prescribe biosimilars
• Multiple manufacturing complexities
• Development of alternative therapies
• Complicated regulatory framework
PART 17: Impact of drivers and challenges
PART 18: Market trends
• Advent of biosimilars expected to improve the treatment rates
• Outsourcing of biosimilar manufacturing activities
• High growth in the emerging markets
PART 19: Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 20: Key vendor analysis
• F. Hoffmann-La Roche
• Amgen
• Johnson & Johnson
• Kyowa Hakko Kirin
PART 21: Appendix
• List of abbreviations
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for erythropoietin drugs 2016
Exhibit 03: Impact of key customer segments on the market 2016
Exhibit 04: Definition of biosimilars in different regions
Exhibit 05: Comparison between biosimilars and generics
Exhibit 06: Factors affecting biologics and biosimilars market
Exhibit 07: Impact of biosimilars cost savings on various sectors
Exhibit 08: Factors affecting success of biosimilars
Exhibit 09: Biosimilars industry: Point-of-view
Exhibit 10: Factors influencing uptake of biosimilars
Exhibit 11: Global erythropoietin drugs market: Strategic factors for new biosimilar entrants
Exhibit 12: Challenges for new entrants
Exhibit 13: Historical timeline of EPO development
Exhibit 14: Globally approved EPO biosimilars
Exhibit 15: Overview of global erythropoietin drugs market (2016-2021)
Exhibit 16: Global erythropoietin drugs market 2016-2021 ($ billions)
Exhibit 17: Key strategies in global erythropoietin drugs market
Exhibit 18: Prospects of the global erythropoietin drugs market
Exhibit 19: Global erythropoietin drugs market snapshot: Developed and emerging markets 2016
Exhibit 20: New opportunities in global erythropoietin drugs market
Exhibit 21: Impact of factors affecting the market 2016 and 2021
Exhibit 22: Factors affecting global erythropoietin drugs market
Exhibit 23: Five forces analysis
Exhibit 24: Share of pipeline molecules
Exhibit 25: Pipeline share of biologics and biosimilars in global erythropoietin drugs market 2016
Exhibit 26: Phase III pipeline portfolio
Exhibit 27: Phase II pipeline portfolio
Exhibit 28: Phase I pipeline portfolio
Exhibit 29: Pre-clinical pipeline portfolio
Exhibit 30: Share of biologics and biosimilars in global erythropoietin drugs market 2016
Exhibit 31: Synopsis of marketed products
Exhibit 32: Biosimilars market segmentation by end-user 2016
Exhibit 33: Global erythropoietin drugs market segmentation in by product type 2016
Exhibit 34: Snapshot of global erythropoietin drugs market by geography
Exhibit 35: Erythropoietin drugs market revenue by geography 2016-2021 ($ billions)
Exhibit 36: Overview of erythropoietin drugs market in EMEA (2016)
Exhibit 37: Erythropoietin drugs market in EMEA 2016-2021 ($ billions)
Exhibit 38: Share of erythropoietin drugs market in Europe 2016
Exhibit 39: Erythropoietin drugs market in Europe 2016-2021 ($ billions)
Exhibit 40: Europe erythropoietin drugs market: Opportunity analysis
Exhibit 41: Analysis of erythropoietin biosimilar marketed products in Europe
Exhibit 42: PEST analysis: Erythropoietin drugs market in Europe 2016
Exhibit 43: Overview of erythropoietin drugs market in Americas (2016)
Exhibit 44: Erythropoietin drugs market in Americas 2016-2021 ($ billions)
Exhibit 45: Erythropoietin drugs market in US 2016-2021 ($ billions)
Exhibit 46: Erythropoietin drugs market in US: Opportunity analysis
Exhibit 47: PEST analysis: Erythropoietin drugs market in US
Exhibit 48: Overview of erythropoietin drugs market in APAC (2016)
Exhibit 49: Erythropoietin drugs market in APAC 2016-2021 ($ billions)
Exhibit 50: Market share of erythropoietin drugs in APAC
Exhibit 51: Erythropoietin drugs market in China 2016-2021 ($ millions)
Exhibit 52: China erythropoietin drugs market: Opportunity analysis
Exhibit 53: PEST analysis: Erythropoietin drugs market in China
Exhibit 54: Erythropoietin drugs market in Japan 2016-2021 ($ millions)
Exhibit 55: Erythropoietin drugs market in Japan 2016: Opportunity analysis
Exhibit 56: PEST analysis: Erythropoietin drugs market in Japan 2016
Exhibit 57: Impact of drivers and challenges in global erythropoietin drugs market
Exhibit 58: Patent analysis of biologicals in the US
Exhibit 59: Patent analysis of biologicals in Europe
Exhibit 60: Impact of drivers
Exhibit 61: Key reasons why physicians are reluctant to prescribe biosimilar drugs
Exhibit 62: Approval process of biologicals versus biosimilars via Public Health Service Act (PHSA) in US
Exhibit 63: Impact of drivers and challenges
Exhibit 64: Impact of trends in global erythropoietin drugs market
Exhibit 65: Few biosimilars currently under pipeline
Exhibit 66: Competitive structure analysis of global erythropoietin drugs market 2016
Exhibit 67: Geographical presence of key vendors
Exhibit 68: Competitive scenario: Global erythropoietin drugs market vendors 2016-2021
Exhibit 69: F. Hoffmann La-Roche: Key highlights
Exhibit 70: F. Hoffmann La-Roche: Strength assessment
Exhibit 71: F. Hoffmann La-Roche: Strategy assessment
Exhibit 72: F. Hoffmann La-Roche: Opportunity assessment
Exhibit 73: Amgen: Key highlights
Exhibit 74: Amgen: Strength assessment
Exhibit 75: Amgen: Strategy assessment
Exhibit 76: Amgen: Opportunity assessment
Exhibit 77: Johnson & Johnson: Profile
Exhibit 78: Johnson & Johnson: Strength assessment
Exhibit 79: Johnson & Johnson: Strategy assessment
Exhibit 80: Johnson & Johnson: Opportunity assessment
Exhibit 81: Kyowa Hakko Kirin: Highlights
Exhibit 82: Kyowa Hakko Kirin: Strength assessment
Exhibit 83: Kyowa Hakko Kirin: Strategy assessment
Exhibit 84: Kyowa Hakko Kirin: Opportunity assessment
【レポート販売概要】
■ タイトル：エリスロポエチン（EPO）薬の世界市場2017-2021■ 英文：Global Erythropoietin Drugs Market 2017-2021
■ 発行日：2017年3月7日
■ 調査会社：Technavio
■ 商品コード：IRTNTR12169
■ 調査対象地域：グローバル
- アレルギー免疫療法の世界市場2016-2020About the Allergy Immunotherapies Market Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. Its administration includes increasing the doses of allergen extracts over a span of time either through injections or sublingual tablets and drops. Alle …
- 世界の産業用ボイラー市場動向（2014-2018）TechNavio's analysts forecast the Global Industrial Boiler market to grow at a CAGR of 2.57 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for industrial boilers from developing countries. The Global Industrial Boiler market has also been witnessing the increasing adoption of CFB boilers in the Power industry. However, the need …
- スパークリングワインの世界市場2016-2020 About Sparkling Wine Sparkling wine is a carbonated wine which is made by fermentation of sugar and yeast. This results in the production of the alcohol and CO2, and since the gas is not allowed to escape, it ultimately mixes with the wine. This is released in the form of tiny bubbles when the bottle is opened, creating a popping sound. Technavio’s analysts forecast the global sparkling wine marke …
- 次世代バイオロジックス（生物製剤）市場：技術、産業、市場（2014-2024）Emerging biological drugs – discover R&D, business analysis, and revenue forecasts What’s the future of biologics, especially new drug classes? Now get the latest technological and commercial analysis. Staying ahead in data and knowledge, you benefit your authority. And you explore trends, developments, results, opportunities, and sales predictions. So visiongain’s new report shows you what’s poss …
- 無線・モバイル端末及びアプリケーション：ソリューションと市場機会：Wireless/Mobile Devices and Applications: Solutions and Market OpportunitiesWireless/Mobile Devices and Applications: Solutions and Market Opportunities is the most comprehensive research package available in the market focusing on wireless/mobile devices and applications. It includes many reports addressing wireless/mobile device developments covering everything from smart phones to tablet computing. It also includes analysis of many different applications and value-adde …
- エアマットレス・ベッドの世界市場2018-2022About Air Mattress and Beds Air mattress and beds are inflatable sleeping pads that use air rather than a coil system or foam core as a means of support to the user. Air chambers that run through the mattress and beds allow the user to adjust and customize comfort while using them. Technavio’s analysts forecast the Global Air Mattress and Beds Market to grow at a CAGR of 9.53% during the period 20 …
- 咳(Cough)：治療薬開発パイプライン動向（2015年上半期版）Cough - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Cough - Pipeline Review, H1 2015’, provides an overview of the Cough’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cough, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) …
- 世界の3Dマッピング及び3Dモデリング市場The past decade witnessed a giant leap in various industries, with 3D technology being implemented in various electronic devices and other objects. The need for 3D mapping arose after an attempt to make 2D maps more advanced and look more real. This was done by introducing sensors, cameras, scanners, GPS components, and other acquisition devices to capture the real time 3D images which are created …
- Saudi ArabiaのVaccines, Veterinary Use市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for vaccines, veterinary use. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on vaccines, veterinary use export/import operations in Saudi Arabia. The 2002-2 …
- 業務用ガスフライヤーの世界市場2017-2021ABSTRACTAbout Commercial Gas Fryer A commercial gas fryer is a kitchen appliance used for deep frying with the help of heat sources such as natural gas and propane gas. These come in two forms: countertop and floor standing models. The market is primarily driven by the increasing number of foodservice establishments providing fried food items, which largely include breaded poultry and fish items, …
- Chaparral Energy, Inc.：石油・ガスバリューチェーン分析レポート2013Chaparral Energy, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Chaparral Energy, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Chaparral Energy, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- 急性腎不全(急性腎傷害)(Acute Renal Failure)の治療薬パイプライン動向（2015年上半期版）Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Renal Failure (ARF) (Acute …
- 世界のウェルインターベンション市場The report covers the global well intervention services market which includes different types of well intervention services, their application areas, and other related segments. It studies the extent of end use of well intervention services in different application areas with respect to different regions. The report gives insights about the tools and technologies being used. It also analyses the m …
- ソーシャルネットワーク広告の世界市場2016-2020Technavio’s research analyst predicts the global social networking market to grow at a CAGR of around 18% during the forecast period. Social media advertising has gained popularity over the past decade, mainly due to the active participation of social media users. Social media advertising offers a solid platform for advertisers to exhibit their brands/products, especially during global events, whi …
- 世界の電力産業におけるDCS（分散制御システム）市場About DCS A DCS is an automated control system that, rather than being centralized, is distributed across an entire organization. DCS is distributed in such a way that each component or sub-system of a manufacturing plant is controlled by one or more controllers, thereby providing instructions to different parts of the plant. Thus, instead of having a centrally located control system, each section …
